253 related articles for article (PubMed ID: 29898360)
1. Perturbation-Theory and Machine Learning (PTML) Model for High-Throughput Screening of Parham Reactions: Experimental and Theoretical Studies.
Simón-Vidal L; García-Calvo O; Oteo U; Arrasate S; Lete E; Sotomayor N; González-Díaz H
J Chem Inf Model; 2018 Jul; 58(7):1384-1396. PubMed ID: 29898360
[TBL] [Abstract][Full Text] [Related]
2. Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide Peptidomimetics.
Ferreira da Costa J; Silva D; Caamaño O; Brea JM; Loza MI; Munteanu CR; Pazos A; García-Mera X; González-Díaz H
ACS Chem Neurosci; 2018 Nov; 9(11):2572-2587. PubMed ID: 29791132
[TBL] [Abstract][Full Text] [Related]
3. PTML Combinatorial Model of ChEMBL Compounds Assays for Multiple Types of Cancer.
Bediaga H; Arrasate S; González-Díaz H
ACS Comb Sci; 2018 Nov; 20(11):621-632. PubMed ID: 30240186
[TBL] [Abstract][Full Text] [Related]
4. Multioutput Perturbation-Theory Machine Learning (PTML) Model of ChEMBL Data for Antiretroviral Compounds.
Vásquez-Domínguez E; Armijos-Jaramillo VD; Tejera E; González-Díaz H
Mol Pharm; 2019 Oct; 16(10):4200-4212. PubMed ID: 31426639
[TBL] [Abstract][Full Text] [Related]
5. PTML Model for Selection of Nanoparticles, Anticancer Drugs, and Vitamins in the Design of Drug-Vitamin Nanoparticle Release Systems for Cancer Cotherapy.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; Montemore MM; González-Díaz H
Mol Pharm; 2020 Jul; 17(7):2612-2627. PubMed ID: 32459098
[TBL] [Abstract][Full Text] [Related]
6. Predicting Metabolic Reaction Networks with Perturbation-Theory Machine Learning (PTML) Models.
Diéguez-Santana K; Casañola-Martin GM; Green JR; Rasulev B; González-Díaz H
Curr Top Med Chem; 2021; 21(9):819-827. PubMed ID: 33797370
[TBL] [Abstract][Full Text] [Related]
7. Designing nanoparticle release systems for drug-vitamin cancer co-therapy with multiplicative perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2019 Nov; 11(45):21811-21823. PubMed ID: 31691701
[TBL] [Abstract][Full Text] [Related]
8. PTML Model of ChEMBL Compounds Assays for Vitamin Derivatives.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva Caracuel E; González-Díaz H
ACS Comb Sci; 2020 Mar; 22(3):129-141. PubMed ID: 32011854
[TBL] [Abstract][Full Text] [Related]
9. Predicting coated-nanoparticle drug release systems with perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2020 Jul; 12(25):13471-13483. PubMed ID: 32613998
[TBL] [Abstract][Full Text] [Related]
10. PTML Multi-Label Algorithms: Models, Software, and Applications.
Ortega-Tenezaca B; Quevedo-Tumailli V; Bediaga H; Collados J; Arrasate S; Madariaga G; Munteanu CR; Cordeiro MNDS; González-Díaz H
Curr Top Med Chem; 2020; 20(25):2326-2337. PubMed ID: 32938352
[TBL] [Abstract][Full Text] [Related]
11. Perturbation-Theory Machine Learning (PTML) Multilabel Model of the ChEMBL Dataset of Preclinical Assays for Antisarcoma Compounds.
Cabrera-Andrade A; López-Cortés A; Munteanu CR; Pazos A; Pérez-Castillo Y; Tejera E; Arrasate S; González-Díaz H
ACS Omega; 2020 Oct; 5(42):27211-27220. PubMed ID: 33134682
[TBL] [Abstract][Full Text] [Related]
12. Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [
Diez-Alarcia R; Yáñez-Pérez V; Muneta-Arrate I; Arrasate S; Lete E; Meana JJ; González-Díaz H
ACS Chem Neurosci; 2019 Nov; 10(11):4476-4491. PubMed ID: 31618004
[TBL] [Abstract][Full Text] [Related]
13. PTML Model for Proteome Mining of B-Cell Epitopes and Theoretical-Experimental Study of Bm86 Protein Sequences from Colima, Mexico.
Martínez-Arzate SG; Tenorio-Borroto E; Barbabosa Pliego A; Díaz-Albiter HM; Vázquez-Chagoyán JC; González-Díaz H
J Proteome Res; 2017 Nov; 16(11):4093-4103. PubMed ID: 28922600
[TBL] [Abstract][Full Text] [Related]
14. PTML Modeling for Alzheimer's Disease: Design and Prediction of Virtual Multi-Target Inhibitors of GSK3B, HDAC1, and HDAC6.
Kleandrova VV; Speck-Planche A
Curr Top Med Chem; 2020; 20(19):1661-1676. PubMed ID: 32515311
[TBL] [Abstract][Full Text] [Related]
15. General theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry.
González-Díaz H; Arrasate S; Gómez-SanJuan A; Sotomayor N; Lete E; Besada-Porto L; Ruso JM
Curr Top Med Chem; 2013; 13(14):1713-41. PubMed ID: 23889050
[TBL] [Abstract][Full Text] [Related]
16. Mapping chemical structure-activity information of HAART-drug cocktails over complex networks of AIDS epidemiology and socioeconomic data of U.S. counties.
Herrera-Ibatá DM; Pazos A; Orbegozo-Medina RA; Romero-Durán FJ; González-Díaz H
Biosystems; 2015 Jun; 132-133():20-34. PubMed ID: 25916548
[TBL] [Abstract][Full Text] [Related]
17. Perturbation Theory Machine Learning Models: Theory, Regulatory Issues, and Applications to Organic Synthesis, Medicinal Chemistry, Protein Research, and Technology.
Arrasate S; Duardo-Sanchez A
Curr Top Med Chem; 2018; 18(14):1203-1213. PubMed ID: 30095052
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning and Perturbation Theory Machine Learning (PTML) in Medicinal Chemistry, Biotechnology, and Nanotechnology.
Herrera-Ibatá DM
Curr Top Med Chem; 2021; 21(7):649-660. PubMed ID: 33475073
[TBL] [Abstract][Full Text] [Related]
19. Predicting Thermodynamic Properties of Alkanes by High-Throughput Force Field Simulation and Machine Learning.
Gong Z; Wu Y; Wu L; Sun H
J Chem Inf Model; 2018 Dec; 58(12):2502-2516. PubMed ID: 30205676
[TBL] [Abstract][Full Text] [Related]
20. PTML modeling for peptide discovery: in silico design of non-hemolytic peptides with antihypertensive activity.
Kleandrova VV; Rojas-Vargas JA; Scotti MT; Speck-Planche A
Mol Divers; 2022 Oct; 26(5):2523-2534. PubMed ID: 34802116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
